Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$7.87 - $10.89 $149,530 - $206,910
-19,000 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$5.07 - $10.9 $39,546 - $85,020
7,800 Added 69.64%
19,000 $188,000
Q4 2017

Feb 12, 2018

SELL
$4.0 - $5.98 $123,208 - $184,195
-30,802 Reduced 73.33%
11,200 $60,000
Q3 2017

Nov 13, 2017

BUY
$2.91 - $4.93 $122,225 - $207,069
42,002
42,002 $207,000

Others Institutions Holding AGLE

# of Institutions
1
Shares Held
241K
Call Options Held
0
Put Options Held
0

About Aeglea BioTherapeutics, Inc.


  • Ticker AGLE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,172,500
  • Market Cap $1.69B
  • Description
  • Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...
More about AGLE
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.